Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3087% below fair value
$2.35+0.01 (+0.43%)
Close on Nov 17, 2026Market cap $347.30MP/E –Yield –
Tilray Brands operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Tilray Brands's operating cash flow for the twelve months ending Aug 31, 2026 was -$84.34M. For fiscal 2026 it was -$69.14M. The highest annual figure on record is $7.91M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$69.14M | – |
| FY2025 | May 31, 2025 | -$94.60M | – |
| FY2024 | May 31, 2024 | -$30.91M | -490.9% |
| FY2023 | May 31, 2023 | $7.91M | – |
| FY2022 | May 31, 2022 | -$177.26M | – |
| FY2019 | Dec 31, 2019 | -$258.07M | – |
| FY2018 | Dec 31, 2018 | -$46.25M | – |
| FY2017 | Dec 31, 2017 | -$6.00M | – |
| FY2016 | Dec 31, 2016 | -$3.32M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$16.54M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$37.32M | – |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$21.94M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$8.54M | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$1.34M | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$12.81M | -141.7% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$5.76M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$40.72M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$35.31M | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $30.71M | -29.6% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$15.36M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$30.41M | -204.1% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$15.84M | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $43.60M | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$18.63M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $29.21M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$46.27M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$20.52M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$46.39M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$17.12M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$93.23M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$90.81M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$57.03M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$85.39M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$24.84M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$19.81M | -2310.7% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$23.54M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$1.18M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$1.73M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $896.00K | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -$4.09M | – |
See a number that looks wrong?